Albireo Pharma Inc - Company Profile

Powered by

All the sales intelligence you need on Albireo Pharma Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Albireo Pharma Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Albireo Pharma Inc.

Back to companies

Albireo Pharma Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Albireo Pharma Inc, a subsidiary of Ipsen SA, is a clinical-stage biopharmaceutical company focused on developing novel bile acid modulators to address unmet needs in orphan pediatric liver diseases. Its activities involve research and development of therapeutic solutions targeting rare liver conditions. Its major products include bile acid modulators designed to treat specific liver disorders. The company is headquartered in Boston, Massachusetts, the US.

 Gain a 360-degree view of Albireo Pharma Inc and make more informed decisions for your business Gain a 360-degree view of Albireo Pharma Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 53 State Street, Boston, Massachusetts, 02109
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Albireo Pharma Inc premium industry data and analytics

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Albireo Pharma Inc’s relevant decision makers and contact details.

50+

Clinical Trials

Determine Albireo Pharma Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Catalyst Calendar

Proactively evaluate Albireo Pharma Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Albireo Pharma Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Albireo Pharma Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Albireo Pharma Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services
Understand Albireo Pharma Inc portfolio and identify potential areas for collaboration Understand Albireo Pharma Inc portfolio and identify potential areas for collaboration Learn more
Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Albireo Pharma Inc key executives to enhance your sales strategy Gain insight into Albireo Pharma Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?